{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:22:05Z","timestamp":1776399725672,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,7]]},"DOI":"10.7759\/cureus.80231","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T23:02:56Z","timestamp":1741388576000},"source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 and Its Effects on the Hepatobiliary System: A Literature Review"],"prefix":"10.7759","author":[{"given":"Sariya","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumana","family":"Hussain Timraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourah A","family":"Al Ghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada Y","family":"Metwali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten A","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albatool M","family":"Alshaqha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Turkistani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Dwaima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibraheem","family":"Ali Algarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000513593","article-title":"Impact of liver test abnormalities and chronic liver disease on the clinical outcomes of patients hospitalized with COVID-19","volume":"158","author":"Garrido M","year":"2021","unstructured":"Garrido M, Pereira Guedes T, Alves Silva J, et al.. Impact of liver test abnormalities and chronic liver disease on the clinical outcomes of patients hospitalized with COVID-19. GE Port J Gastroenterol. 2021, 158:1-12. 10.1159\/000513593","journal-title":"GE Port J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-020-00691-6","article-title":"Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2","volume":"9","author":"Zhang XY","year":"2020","unstructured":"Zhang XY, Huang HJ, Zhuang DL, Nasser MI, Yang MH, Zhu P, Zhao MY. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Infect Dis Poverty. 2020, 9:99. 10.1186\/s40249-020-00691-6","journal-title":"Infect Dis Poverty"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang Y","year":"2020","unstructured":"Wang Y, Liu S, Liu H, et al.. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020, 73:807-16. 10.1016\/j.jhep.2020.05.002","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.12671","article-title":"The novel zoonotic COVID-19 pandemic: an expected global health concern","volume":"14","author":"Contini C","year":"2020","unstructured":"Contini C, Di Nuzzo M, Barp N, Bonazza A, De Giorgio R, Tognon M, Rubino S. The novel zoonotic COVID-19 pandemic: an expected global health concern. J Infect Dev Ctries. 2020, 14:254-64. 10.3855\/jidc.12671","journal-title":"J Infect Dev Ctries"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-00240-0","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo YR","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, et al.. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020, 7:11. 10.1186\/s40779-020-00240-0","journal-title":"Mil Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1739","article-title":"Longitudinal analysis of the utility of liver biochemistry as prognostic markers in hospitalized patients with corona virus disease 2019","volume":"5","author":"Wang T","year":"2021","unstructured":"Wang T, Smith DA, Campbell C, et al.. Longitudinal analysis of the utility of liver biochemistry as prognostic markers in hospitalized patients with corona virus disease 2019. Hepatol Commun. 2021, 5:1586-604. 10.1002\/hep4.1739","journal-title":"Hepatol Commun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-024-02332-y","article-title":"Liver injury in COVID-19: an insight into pathobiology and roles of risk factors","volume":"21","author":"Tazarghi A","year":"2024","unstructured":"Tazarghi A, Bazoq S, Taziki Balajelini MH, Ebrahimi M, Hosseini SM, Razavi Nikoo H. Liver injury in COVID-19: an insight into pathobiology and roles of risk factors. Virol J. 2024, 21:65. 10.1186\/s12985-024-02332-y","journal-title":"Virol J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.07.008","article-title":"Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper","volume":"77","author":"Marjot T","year":"2022","unstructured":"Marjot T, Eberhardt CS, Boettler T, et al.. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper. J Hepatol. 2022, 77:1161-97. 10.1016\/j.jhep.2022.07.008","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111411","article-title":"Cytokine storm in COVID-19: exploring IL-6 signaling and cytokine-microbiome interactions as emerging therapeutic approaches","volume":"25","author":"Paranga TG","year":"2024","unstructured":"Paranga TG, Mitu I, Pavel-Tanasa M, et al.. Cytokine storm in COVID-19: exploring IL-6 signaling and cytokine-microbiome interactions as emerging therapeutic approaches. Int J Mol Sci. 2024, 25:11411. 10.3390\/ijms252111411","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i47.6662","article-title":"Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review","volume":"28","author":"Polyzogopoulou E","year":"2022","unstructured":"Polyzogopoulou E, Amoiridou P, Abraham TP, Ventoulis I. Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review. World J Gastroenterol. 2022, 28:6662-88. 10.3748\/wjg.v28.i47.6662","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2021.00368","article-title":"Impact of liver functions by repurposed drugs for COVID-19 treatment","volume":"10","author":"Zhang R","year":"2022","unstructured":"Zhang R, Wang Q, Yang J. Impact of liver functions by repurposed drugs for COVID-19 treatment. J Clin Transl Hepatol. 2022, 10:748-56. 10.14218\/JCTH.2021.00368","journal-title":"J Clin Transl Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14730","article-title":"Pathophysiological mechanisms of liver injury in COVID-19","volume":"41","author":"Nardo AD","year":"2021","unstructured":"Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021, 41:20-32. 10.1111\/liv.14730","journal-title":"Liver Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i45.6314","article-title":"Liver injury induced by COVID 19 treatment - what do we know?","volume":"28","author":"Saha L","year":"2022","unstructured":"Saha L, Vij S, Rawat K. Liver injury induced by COVID 19 treatment - what do we know?. World J Gastroenterol. 2022, 28:6314-27. 10.3748\/wjg.v28.i45.6314","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2004-127","article-title":"Coronaviruses and SARS-COV-2","volume":"50","author":"Has\u00f6ks\u00fcz M","year":"2020","unstructured":"Has\u00f6ks\u00fcz M, Kili\u00e7 S, Sara\u00e7 F. Coronaviruses and SARS-COV-2. Turk J Med Sci. 2020, 50:549-56. 10.3906\/sag-2004-127","journal-title":"Turk J Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu Z","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, et al.. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020, 8:420-2. 10.1016\/S2213-2600(20)30076-X","journal-title":"Lancet Respir Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris JS","year":"2003","unstructured":"Peiris JS, Lai ST, Poon LL, et al.. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003, 361:1319-25. 10.1016\/s0140-6736(03)13077-2","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020, 382:727-33. 10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31480","article-title":"Abnormal liver function tests in patients with COVID-19: relevance and potential pathogenesis","volume":"72","author":"Bertolini A","year":"2020","unstructured":"Bertolini A, van de Peppel IP, Bodewes FA, et al.. Abnormal liver function tests in patients with COVID-19: relevance and potential pathogenesis. Hepatology. 2020, 72:1864-72. 10.1002\/hep.31480","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31404","article-title":"Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. cohort","volume":"72","author":"Phipps MM","year":"2020","unstructured":"Phipps MM, Barraza LH, LaSota ED, et al.. Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. cohort. Hepatology. 2020, 72:807-17. 10.1002\/hep.31404","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson S","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al.. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020, 323:2052-9. 10.1001\/jama.2020.6775","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.030","article-title":"Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2","volume":"73","author":"De Smet V","year":"2020","unstructured":"De Smet V, Verhulst S, van Grunsven LA. Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2. J Hepatol. 2020, 73:993-5. 10.1016\/j.jhep.2020.05.030","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.03.931766","article-title":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection (Preprint)","author":"Chai X","year":"2020","unstructured":"Chai X, Hu L, Zhang Y, et al.. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection (Preprint). bioRxiv. 2020, 10.1101\/2020.02.03.931766","journal-title":"bioRxiv"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/cells12020262","article-title":"Pathogenesis and mechanisms of SARS-CoV-2 infection in the intestine, liver, and pancreas","volume":"12","author":"Khreefa Z","year":"2023","unstructured":"Khreefa Z, Barbier MT, Koksal AR, Love G, Del Valle L. Pathogenesis and mechanisms of SARS-CoV-2 infection in the intestine, liver, and pancreas. Cells. 2023, 12:262. 10.3390\/cells12020262","journal-title":"Cells"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2007.10.031","article-title":"The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome","volume":"26","author":"Wang H","year":"2008","unstructured":"Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med. 2008, 26:711-5. 10.1016\/j.ajem.2007.10.031","journal-title":"Am J Emerg Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100777","article-title":"A review on how to do hematology consults during COVID-19 pandemic","volume":"47","author":"Sahu KK","year":"2021","unstructured":"Sahu KK, Cerny J. A review on how to do hematology consults during COVID-19 pandemic. Blood Rev. 2021, 47:100777. 10.1016\/j.blre.2020.100777","journal-title":"Blood Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa247","article-title":"A comparative study on the clinical features of coronavirus 2019 (COVID-19) pneumonia with other pneumonias","volume":"71","author":"Zhao D","year":"2020","unstructured":"Zhao D, Yao F, Wang L, et al.. A comparative study on the clinical features of coronavirus 2019 (COVID-19) pneumonia with other pneumonias. Clin Infect Dis. 2020, 71:756-61. 10.1093\/cid\/ciaa247","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13440","article-title":"SARS-CoV-2 infection in patients with a normal or abnormal liver","volume":"28","author":"Cabibbo G","year":"2021","unstructured":"Cabibbo G, Rizzo GE, Stornello C, Crax\u00ec A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepat. 2021, 28:4-11. 10.1111\/jvh.13440","journal-title":"J Viral Hepat"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0328-2","article-title":"COVID-19 and the liver-related deaths to come","volume":"17","author":"Pawlotsky JM","year":"2020","unstructured":"Pawlotsky JM. COVID-19 and the liver-related deaths to come. Nat Rev Gastroenterol Hepatol. 2020, 17:523-5. 10.1038\/s41575-020-0328-2","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1745","article-title":"Impact of COVID-19 in liver disease progression","volume":"5","author":"Martinez MA","year":"2021","unstructured":"Martinez MA, Franco S. Impact of COVID-19 in liver disease progression. Hepatol Commun. 2021, 5:1138-50. 10.1002\/hep4.1745","journal-title":"Hepatol Commun"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.035","article-title":"No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease","volume":"73","author":"Biquard L","year":"2020","unstructured":"Biquard L, Valla D, Rautou PE. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease. J Hepatol. 2020, 73:717-8. 10.1016\/j.jhep.2020.04.035","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10084-4","article-title":"Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis","volume":"14","author":"Grace JA","year":"2020","unstructured":"Grace JA, Casey S, Burrell LM, Angus PW. Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis. Hepatol Int. 2020, 14:884-5. 10.1007\/s12072-020-10084-4","journal-title":"Hepatol Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020, 395:1033-4. 10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos A","year":"2014","unstructured":"Albillos A, Lario M, \u00c1lvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014, 61:1385-96. 10.1016\/j.jhep.2014.08.010","journal-title":"J Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla S","year":"2021","unstructured":"Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Dis (Hoboken). 2021, 17:365-70. 10.1002\/cld.1061","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13362","article-title":"Clinical characteristics in patients with SARS-CoV-2\/HBV co-infection","volume":"27","author":"Chen L","year":"2020","unstructured":"Chen L, Huang S, Yang J, Cheng X, Shang Z, Lu H, Cheng J. Clinical characteristics in patients with SARS-CoV-2\/HBV co-infection. J Viral Hepat. 2020, 27:1504-7. 10.1111\/jvh.13362","journal-title":"J Viral Hepat"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.06.017","article-title":"Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV coinfection","volume":"19","author":"Zou X","year":"2021","unstructured":"Zou X, Fang M, Li S, et al.. Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV coinfection. Clin Gastroenterol Hepatol. 2021, 19:597-603. 10.1016\/j.cgh.2020.06.017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14449","article-title":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study","volume":"40","author":"Xie H","year":"2020","unstructured":"Xie H, Zhao J, Lian N, Lin S, Xie Q, Zhuo H. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study. Liver Int. 2020, 40:1321-6. 10.1111\/liv.14449","journal-title":"Liver Int"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases","volume":"61","author":"Negro F","year":"2014","unstructured":"Negro F. Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases. J Hepatol. 2014, 61:69-78. 10.1016\/j.jhep.2014.08.003","journal-title":"J Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang W","year":"2020","unstructured":"Liang W, Guan W, Chen R, et al.. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020, 21:335-7. 10.1016\/S1470-2045(20)30096-6","journal-title":"Lancet Oncol"},{"key":"ref41","unstructured":"Cancer Today. (2021). Accessed. 24 September 2021: https:\/\/gco.iarc.fr\/en."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang L","year":"2020","unstructured":"Zhang L, Zhu F, Xie L, et al.. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020, 31:894-901. 10.1016\/j.annonc.2020.03.296","journal-title":"Ann Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001806","article-title":"Case series and review of liver dysfunction in COVID-19 patients","volume":"32","author":"Kudaravalli P","year":"2020","unstructured":"Kudaravalli P, Saleem SA, Ibeche B, John S. Case series and review of liver dysfunction in COVID-19 patients. Eur J Gastroenterol Hepatol. 2020, 32:1244-50. 10.1097\/MEG.0000000000001806","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i31.4694","article-title":"Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan","volume":"26","author":"Zhang H","year":"2020","unstructured":"Zhang H, Liao YS, Gong J, Liu J, Zhang H. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan. World J Gastroenterol. 2020, 26:4694-702. 10.3748\/wjg.v26.i31.4694","journal-title":"World J Gastroenterol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: abnormal liver function tests","volume":"73","author":"Cai Q","year":"2020","unstructured":"Cai Q, Huang D, Yu H, et al.. COVID-19: abnormal liver function tests. J Hepatol. 2020, 73:566-74. 10.1016\/j.jhep.2020.04.006","journal-title":"J Hepatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2021.01.001","article-title":"Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19","volume":"5","author":"Higuera-de la Tijera F","year":"2021","unstructured":"Higuera-de la Tijera F, Serv\u00edn-Caama\u00f1o A, Reyes-Herrera D, et al.. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19. Liver Res. 2021, 5:21-7. 10.1016\/j.livres.2021.01.001","journal-title":"Liver Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89340-y","article-title":"Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity","volume":"11","author":"Wagner J","year":"2021","unstructured":"Wagner J, Garcia-Rodriguez V, Yu A, et al.. Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity. Sci Rep. 2021, 11:10308. 10.1038\/s41598-021-89340-y","journal-title":"Sci Rep"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26055","article-title":"COVID-19 and liver dysfunction: a systematic review and meta-analysis of retrospective studies","volume":"92","author":"Youssef M","year":"2020","unstructured":"Youssef M, H Hussein M, Attia AS, et al.. COVID-19 and liver dysfunction: a systematic review and meta-analysis of retrospective studies. J Med Virol. 2020, 92:1825-33. 10.1002\/jmv.26055","journal-title":"J Med Virol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.008","article-title":"Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases","volume":"75","author":"Thuluvath PJ","year":"2021","unstructured":"Thuluvath PJ, Robarts P, Chauhan M. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. J Hepatol. 2021, 75:1434-9. 10.1016\/j.jhep.2021.08.008","journal-title":"J Hepatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0203","article-title":"Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK","volume":"30","author":"Lee K","year":"2024","unstructured":"Lee K, Park J, Lee J, et al.. Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK. Clin Mol Hepatol. 2024, 30:943-58. 10.3350\/cmh.2024.0203","journal-title":"Clin Mol Hepatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2021.09.001","article-title":"The clinical implication of gamma-glutamyl transpeptidase in COVID-19","volume":"5","author":"Liu J","year":"2021","unstructured":"Liu J, Yu C, Yang Q, et al.. The clinical implication of gamma-glutamyl transpeptidase in COVID-19. Liver Res. 2021, 5:209-16. 10.1016\/j.livres.2021.09.001","journal-title":"Liver Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29792","article-title":"Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: a comprehensive analysis of the international pharmacovigilance database","volume":"96","author":"Lee S","year":"2024","unstructured":"Lee S, Lee K, Park J, et al.. Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: a comprehensive analysis of the international pharmacovigilance database. J Med Virol. 2024, 96:9792. 10.1002\/jmv.29792","journal-title":"J Med Virol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v11.i10.2226","article-title":"Hepatobiliary system and intestinal injury in new coronavirus infection (COVID-19): a retrospective study","volume":"11","author":"Kozlov KV","year":"2023","unstructured":"Kozlov KV, Zhdanov KV, Ratnikova AK, et al.. Hepatobiliary system and intestinal injury in new coronavirus infection (COVID-19): a retrospective study. World J Clin Cases. 2023, 11:2226-36. 10.12998\/wjcc.v11.i10.2226","journal-title":"World J Clin Cases"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v93iS1.12760","article-title":"Acute acalculous cholecystitis as an early manifestation of COVID-19: case report and literature review","volume":"93","author":"D\u2019Introno A","year":"2022","unstructured":"D\u2019Introno A, Gatti P, Manca G, D\u2019Amuri A, Minniti S, Cirac\u00ec E. Acute acalculous cholecystitis as an early manifestation of COVID-19: case report and literature review. Acta Biomed. 2022, 93:2022207. 10.23750\/abm.v93iS1.12760","journal-title":"Acta Biomed"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335059-covid-19-and-its-effects-on-the-hepatobiliary-system-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T23:02:59Z","timestamp":1741388579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335059-covid-19-and-its-effects-on-the-hepatobiliary-system-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.80231","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}